{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreife2w6pwnaizbbh3rttdfii3ii7hhccu4m3gwfupq52tn6jgemesq",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mmca3fq6bxc2"
  },
  "path": "/business/dr-reddys-launches-oral-semaglutide-biosimilar-obeda-in-india-11523809",
  "publishedAt": "2026-05-20T14:17:01.000Z",
  "site": "https://www.ndtvprofit.com",
  "tags": [
    "Business"
  ],
  "textContent": "Oral semaglutide, a glucagon-Like Peptide-1 receptor agonist (GLP-1 RA), is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes.",
  "title": "Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India"
}